Navigation Links
Par Pharmaceutical Receives Final Approval to Market Generic Ultram(R) ER
Date:11/16/2009

WOODCLIFF LAKE, N.J., Nov. 16 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for the 100mg and 200mg strengths of tramadol ER. Ortho-McNeil sells extended-release tramadol tablets under the brand name Ultram® ER. Par has been awarded 180 days of marketing exclusivity, commencing at launch, for being the first to file an ANDA containing a paragraph IV certification for the product. Annual U.S. sales of the 100mg and 200mg strengths of Ultram® ER are approximately $156 million, according to IMS Health data. Par began shipping tramadol ER to the trade upon approval.

In August, Par announced that the U.S. District Court for the District of Delaware ruled in favor of Par in its challenge of Purdue's patents relating to extended-release tramadol, which are listed in the Orange Book for Ortho-McNeil's Ultram® ER product.

Important information about Tramadol ER

Tramadol hydrochloride is a centrally acting synthetic analgesic in an extended release formulation. Tramadol hydrochloride ER tablets are indicated for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of their pain for an extended period of time.

Tramadol hydrochloride ER tablets should not be administered to patients who have previously demonstrated hypersensitivity to tramadol, any other component of this product or opioids. Tramadol hydrochloride ER tablets are contraindicated in any situation where opioids are contraindicated, including acute intoxication with any of the following: alcohol, hypnotics, narcotics, centrally acting analgesics, opioids or psychotropic drugs. Tramadol hydrochloride ER tabl
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lotus Pharmaceuticals, Inc. Reports Third-Quarter 2009 Results
2. Jiangbo Pharmaceuticals, Inc. Announces Conference Call to Discuss Results for the First Quarter of Fiscal Year 2010
3. KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw Amendments
4. ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009
5. Cempra Pharmaceuticals To Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 17th
6. Tianyin Pharmaceutical co., Inc. Announces Record First Quarter 2010 Financial Results
7. Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
8. Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results
9. Euro RSCG Life Presents Proprietary Survey Insights at Food and Drug Administration Hearing on Pharmaceutical Promotion via Online and Social Media
10. Biostar Pharmaceuticals, Inc. Announces Record Third Quarter 2009 Financial Results
11. Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2010)... Feb. 8 Connectyx Technologies Holdings ... advertising contract with SkyMall Inc. SkyMall produces the ... major airlines seat pockets. SkyMall has an annual ... featuring the MedFlash ® Personal Health Manager ... of contents in the front section of the ...
(Date:2/8/2010)... SAN DIEGO , Feb. 8 /PRNewswire/ ... -based innovator of patient safety solutions that help ... it has closed $30 million in ... TPG Biotech, the leading science-based venture investment arm ... Co-leads for this financing include Camden Partners and ...
(Date:2/8/2010)... ,, ROCKVILLE, Md. , Feb. 8 ... large-scale study of key antimalarial medicines in ten ... of medicines circulating on national markets are of ... growth of drug-resistant strains of Plasmodium falciparum ... findings, released today by the Promoting the Quality ...
Breaking Medicine Technology:Connectyx Announces MedFlash(R) Advertising Contract with SkyMall Inc. 2Connectyx Announces MedFlash(R) Advertising Contract with SkyMall Inc. 3PatientSafe Solutions, Inc. Closes $30 Million Financing 2PatientSafe Solutions, Inc. Closes $30 Million Financing 3One-Third of Antimalarial Medicines Sampled in Three African Nations Found to Be Substandard in Large-Scale USP-WHO Study 2One-Third of Antimalarial Medicines Sampled in Three African Nations Found to Be Substandard in Large-Scale USP-WHO Study 3One-Third of Antimalarial Medicines Sampled in Three African Nations Found to Be Substandard in Large-Scale USP-WHO Study 4One-Third of Antimalarial Medicines Sampled in Three African Nations Found to Be Substandard in Large-Scale USP-WHO Study 5UBA offers Free Webinar 3A NAHU Executive VP and CEO to Discuss Health Reform Bills 53690 1UBA offers Free Webinar 3A NAHU Executive VP and CEO to Discuss Health Reform Bills 53690 2UBA offers Free Webinar 3A NAHU Executive VP and CEO to Discuss Health Reform Bills 53690 3Ten Years Later 3A O I S Media Leads Physician Job Board Industry with Innovative Technology 53688 1Ten Years Later 3A O I S Media Leads Physician Job Board Industry with Innovative Technology 53688 2Cell Therapeutics Inc 28CTI 29 to Report Second Quarter Financial Results on August 6 53686 1
... at ICAD 2008 Highlight Significant Improvement in Cognitive Performance ... ... -, CHICAGO, July 30 Forest Laboratories, Inc.,(NYSE: FRX ... of Namenda(R) (memantine HCl) at the 2008,Alzheimer,s Association International Conference on ...
... Wound Care Innovations, LLC,a subsidiary of Wound ... an evidence based study with a NE podiatric ... care collagen,product, CellerateRx(R), on diabetic venous ulcers. "According ... and Prevention, diabetes now,affects nearly 24 million people ...
Other Medicine Technology:New Data Highlight Positive Results of Namenda(R) (memantine HCl) Once-Daily Extended-Release Formulation 2New Data Highlight Positive Results of Namenda(R) (memantine HCl) Once-Daily Extended-Release Formulation 3New Data Highlight Positive Results of Namenda(R) (memantine HCl) Once-Daily Extended-Release Formulation 4Wound Management Technologies, Inc. Announces Agreement for Evidence Based Study for Diabetic Venous Ulcers 2
(Date:2/9/2010)... The Relief Place, a website that features medical symptoms and relief ... of its own medical supply store, The Relief Shop. So, just ... help you? , ... (PRWEB) February 9, 2010 -- ... equipment for the disabled and elderly, for those with arthritis and ...
(Date:2/8/2010)... likely to use a shade of gray to represent ... journal BMC Medical Research Methodology describe the ... which can be used to study people,s preferred pigment ... Whorwell, Professor of Medicine and Gastroenterology at University Hospital ... the University of Manchester, UK, to create an instrument ...
(Date:2/8/2010)... launches new YouTube contest - named ,My Phonak FM & Me, - ... ... Murten, Switzerland (PRWEB) February 11, 2009 -- Phonak, leading hearing systems manufacturer, ... & Me , - in order to track down the most inspiring ... system users up to the age of 19 the chance to win ...
(Date:2/8/2010)... CHARLOTTE, N.C. , Feb. 8 ... will soon be headed to Haiti . Through ... is organizing volunteer groups who will spend two weeks ... January earthquake. ,, The first contingent of 10 ... will remain in Haiti for two weeks. ...
(Date:2/8/2010)... Fewer prostate cancers were detected by prostate-specific antigen ... European randomized trial because of lower screening sensitivity, ... February 8 in the Journal of the ... PSA screening performance in a clinical trial with ... MSc, Department of Public Health, Erasmus Medical Center, ...
Breaking Medicine News(10 mins):Health News:TheReliefPlace.com Launches Online Store “The Relief Shop” - What Does this Medical Supply Store Carry and How Can They Help You? 2Health News:Depressed people feel more gray than blue 2Health News:Phonak Asks Young FM Users to Tell Their Stories on YouTube 2Health News:Carolinas HealthCare System Volunteers to Join Navy Rescue Mission in Haiti 2Health News:Carolinas HealthCare System Volunteers to Join Navy Rescue Mission in Haiti 3Health News:Lower detection of prostate cancer with PSA screening in US than in a European randomized trial 2
... the Pew Internet Project has revealed that one-third of US ... ,It was found during the ... their private information on the Internet as compared to direct ... were more likely than boys to be targets, and teens ...
... rape of women in sub-Saharan African nations has increased the ... This is according to a new study by UNHCR of ... British medical journal The Lancet. ,There are no data ... host communities; the reverse may be the case. ,The ...
... new type of engineered drug may have the potential to ... researchers at the Ohio State University Comprehensive Cancer Center was ... research has established that an engineered drug candidate is promising ... animal tests. ,The agent represents a new ...
... sparing even tiny tots. Children as young as two are ... ,Anxiety disorders in children are far more prevalent ... ,In children aged 6to 11, the anxiety prevalence rate ... 1 per cent for mood disorders such as depression. ...
... led the private effort to map the human genome, says that ... create the first artificial life form, as he has replaced the ... ,In the breakthrough experiment, the researcher substituted the DNA of ... into a different species. ,The success of his ...
... The Department for International Development (DFID) in Britain has announced ... five years in support of the third phase of ... ,The NACP III is a comprehensive prevention, ... the AIDS epidemic in India by 2012. The announcement was ...
Other Medicine News:Health News:One-third of US Teen Netizens are Victims of Cyber-bullying 2Health News:War Spreading AIDS a Myth-UNHCR 2Health News:New Engineered Drug Shows Promise in Treating Lymphocytic Leukaemia 2Health News:Anxiety Disorders Show in Tiny Tots 2Health News:DNA Transplant Brings Creation of Artificial Life a Step Closer 2
Multi-sided, Sharp all around...
...
Stab incision blades color coded for simple and accurate identification...
Atkinson needles have a single bevel with a 22 angle point. Injecting anesthetic agents into the muscle cone. 0.60mm x 38.0mm (23 G x 1 1/2 in)...
Medicine Products: